Open AccessThe Interleukin-33–Group 2 Innate Lymphoid Cell Axis Represents a Potential Adjuvant Target To Increase the Cross-Protective Efficacy of Influenza Vaccine
Author(s) -
C. M. Williams,
Sreeja Biswas Roy,
Danielle Califano,
Andrew N. J. McKenzie,
Dennis W. Metzger,
Yoichi Furuya
Publication year - 2021
Publication title -
journal of virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.617
H-Index - 292
eISSN - 1070-6321
pISSN - 0022-538X
DOI - 10.1128/jvi.00598-21
Subject(s) - biology , immunology , adjuvant , virology , vaccination , immunity , immune system , humoral immunity , virus , vaccine efficacy , influenza a virus , cytokine , influenza vaccine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom